World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
61
Citations
10228
World Ranking
3738
National Ranking
165

Luca Ferraro publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Luca Ferraro sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 210 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Luca Ferraro D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Luca Ferraro sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 61 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Luca Ferraro is affiliated with the University of Ferrara in Italy and specializes in research primarily within the fields of Biochemistry, Genetics and Molecular Biology, Medicine, and Neuroscience. Their work spans multiple subfields including Molecular Biology, Pharmaceutical Science, Cellular and Molecular Neuroscience, Pharmacology, and Physiology.

Their research topics cover a broad range of subjects with notable focus areas such as Receptor Mechanisms and Signaling, Advanced Drug Delivery Systems, Neuroscience and Neuropharmacology Research, Tryptophan and Brain Disorders, Cannabis and Cannabinoid Research, Bipolar Disorder and Treatment, and Drug Solubility and Delivery Systems.

Luca Ferraro has contributed to a variety of scientific publications, with frequent publication venues including Pharmaceutics, Pharmacological Reports, The Cambridge Structural Database, International Journal of Molecular Sciences, and Frontiers in Pharmacology.

They have collaborated extensively with a number of coauthors, including Sarah Beggiato, Alessandro Dalpiaz, Barbara Pavan, Dasiel O. Borroto-Escuela, and Kjell Fuxé.

Key recent papers authored or coauthored by Luca Ferraro include:

  • Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease, 2020, Journal of Controlled Release
  • Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?, 2021, Pharmaceutics
  • Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery, 2021, Journal of Controlled Release
  • Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease, 2020, Journal of Clinical Medicine
  • Effect of a Fiber D-Limonene-Enriched Food Supplement on Intestinal Microbiota and Metabolic Parameters of Mice on a High-Fat Diet, 2021, Pharmaceutics

Best Publications

  • Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery

    M Bianconi;L Ferraro;G.C. Traina;G Zanoli

  • Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

    Marco Pistis;Luca Ferraro;Luigi Pira;Giovanna Flore

  • The Pharmacokinetics and Efficacy of Ropivacaine Continuous Wound Instillation After Spine Fusion Surgery

    Margherita Bianconi;Luca Ferraro;Riccardo Ricci;Gustavo Zanoli

  • Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.

    Giampaolo Mereu;Mauro Fà;Luca Ferraro;Raffaele Cagiano

  • Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology

    K. Fuxe;D. Marcellino;A. Rivera;Z. Diaz-Cabiale

  • The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

    Luca Ferraro;Tiziana Antonelli;Sergio Tanganelli;William T O’Connor

  • The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism

    Luca Ferraro;Sergio Tanganelli;William Thomas O'Connor;Tiziana Antonelli

  • Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers

    Luca Ferraro;Tiziana Antonelli;William T. O'Connor;Sergio Tanganelli

  • Prenatal Exposure to the CB1 Receptor Agonist WIN 55,212-2 Causes Learning Disruption Associated with Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring

    Tiziana Antonelli;Maria Cristina Tomasini;Maria Tattoli;Tommaso Cassano

  • The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission

    Luca Ferraro;Tiziana Antonelli;William T. O'Connor;Sergio Tanganelli

  • Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.

    Erica Zamberletti;Sarah Beggiato;Luca Steardo;Pamela Prini

  • Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity.

    Stefano Manfredini;Barbara Pavan;Silvia Vertuani;Martina Scaglianti

  • The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

    Luca Ferraro;Sergio Tanganelli;William Thomas O'Connor;Tiziana Antonelli

  • The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.

    Luca Ferraro;Tiziana Antonelli;William O'Connor;Sergio Tanganelli

  • Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate

    Giovanna Rassu;Elena Soddu;Massimo Cossu;Antonio Brundu

  • Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats.

    Patrizia Campolongo;Viviana Trezza;Tommaso Cassano;Silvana Gaetani

  • Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease.

    Dasiel O. Borroto-Escuela;Jens Carlsson;Patricia Ambrogini;Manuel Narvaez

  • Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.

    S. Tanganelli;W.T. O'connor;L. Ferraro;C. Bianchi

  • Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms.

    S. Tanganelli;K. Fuxe;L. Ferraro;A. M. Janson

  • The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmission in Rat Cerebral Cortex: an In Vivo and In Vitro Study

    Luca Ferraro;Maria Cristina Tomasini;Gian Luigi Gessa;Berta Wonjie Bebe

  • Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes.

    Dasiel O. Borroto-Escuela;Karolina Wydra;Julia Pintsuk;Manuel Narvaez

Frequent Co-Authors

Sergio Tanganelli
Sergio Tanganelli University of Ferrara
Tiziana Antonelli
Tiziana Antonelli University of Ferrara
Kjell Fuxe
Kjell Fuxe Karolinska Institute
Dasiel O. Borroto-Escuela
Dasiel O. Borroto-Escuela Karolinska Institute
Lorenzo Beani
Lorenzo Beani University of Ferrara
Tommaso Cassano
Tommaso Cassano University of Foggia
Luigi F. Agnati
Luigi F. Agnati University of Modena and Reggio Emilia
Laura Calzà
Laura Calzà University of Bologna
Silvana Gaetani
Silvana Gaetani Sapienza University of Rome
Rafael Franco
Rafael Franco University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Luca Ferraro

Trending Scientists

Recently Published Articles